Windtree Therapeutics Inc (WINT)
4.14
-0.22
(-5.15%)
USD |
NASDAQ |
May 10, 16:00
4.14
0.00 (0.00%)
After-Hours: 20:00
Windtree Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2019 | 0.1381 |
| March 31, 2019 | 0.1186 |
| December 31, 2018 | 0.1171 |
| September 30, 2018 | -0.1675 |
| June 30, 2018 | -0.0881 |
| March 31, 2018 | -0.0891 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.737 |
| June 30, 2017 | -0.7768 |
| March 31, 2017 | -0.9705 |
| December 31, 2016 | -0.8672 |
| September 30, 2016 | -1.094 |
| June 30, 2016 | -1.643 |
| March 31, 2016 | -5.023 |
| December 31, 2015 | 3.024 |
| September 30, 2015 | 1.397 |
| June 30, 2015 | -6.976 |
| March 31, 2015 | 2.675 |
| December 31, 2014 | 1.061 |
| September 30, 2014 | 0.6853 |
| June 30, 2014 | 0.494 |
| March 31, 2014 | 0.385 |
| December 31, 2013 | 0.3162 |
| September 30, 2013 | 1.155 |
| June 30, 2013 | 0.3688 |
| Date | Value |
|---|---|
| March 31, 2013 | 0.6432 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.2216 |
| March 31, 2010 | 0.828 |
| December 31, 2009 | 8.072 |
| September 30, 2009 | 2.064 |
| June 30, 2009 | 1.11 |
| March 31, 2009 | 2.375 |
| December 31, 2008 | 1.250 |
| September 30, 2008 | 0.8061 |
| June 30, 2008 | 0.4645 |
| March 31, 2008 | 0.4937 |
| December 31, 2007 | 0.3161 |
| September 30, 2007 | 0.5722 |
| June 30, 2007 | 0.3881 |
| March 31, 2007 | 1.261 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1381
Minimum
Jun 2019
0.1381
Maximum
Jun 2019
0.1381
Average
0.1381
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Lexicon Pharmaceuticals Inc | 0.3457 |
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 32.41M |
| Total Liabilities (Quarterly) | 29.02M |
| Shareholders Equity (Quarterly) | 3.391M |